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Abstract
Background: Holmes tremor is a rare symptomatic movement disorder, characterized by a combination of resting, postural, and intention tremor. It is usually
caused by lesions in the brainstem, thalamus, and cerebellum. Despite pharmacological advances, its treatment remains a challenge; many medications have been
used with various degrees of effectiveness. Stereotactic thalamotomy and deep brain stimulation in the ventralis intermedius nucleus have been effective surgical
procedures in cases refractory to medical treatment.
Case Report: Here we report a young woman with topiramate-responsive Holmes tremor secondary to a brainstem cavernoma.
Discussion: Herein we report a Holmes tremor responsive to Topiramate.
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Introduction
Holmes tremor (HT) is characterized by a combination of resting,
postural, and intention tremor and is usually caused by injuries involv-
ing the brainstem, thalamus, cerebellum, or their connections.1
The current definition is derived from the consensus statement of
the Movement Disorder Society on Tremor from 2018.2 It is described
as a syndrome of rest, postural, and intention tremor that usually
appears from proximal and distal rhythmic muscle contraction at low
frequency (,5 Hz). The etiology is frequently an acquired lesion in the
brainstem in the vicinity of the red nucleus. The different etiologies
include ischemic or hemorrhagic cerebrovascular disorders, bleeding
because of vascular malformations, head trauma, tumors, demyelina-
tion, or infections.3–5
Tremor commonly develops between 1 and 24 months after a central
nervous system insult. This delayed onset might be due to neuronal plastic
changes.6–9 HT usually occurs with other localizing signs, but is rarely
isolated.10
As it is a symptomatic tremor, imaging studies are usually abnormal,
although in some cases no lesion at all can be demonstrated.11–14
The treatment is often challenging and only few cases of treatment-
responsive HT have been reported in the literature.15 Here, we report
a patient diagnosed with a brainstem cavernoma who developed HT
responsive to topiramate (TPM).
Case report
A 33-year-old right-handed female, without any relevant medical
history, suffered a sudden left hemiparesis on January 2016. Brain
magnetic resonance imaging (MRI) showed a brainstem hemorrhage,
involving the right mesencephalon, secondary to an extensive cavern-
ous angioma, with diencephalic and thalamic extension (Figures 1 and 2).
Repeated hemorrhages lead to a space-occupying lesion. She under-
went surgery for the hematoma evacuation, but complete resection was
not possible. A few weeks later, she developed a rest tremor, worsening
with posture and additionally intensified with action involving her left
arm. The tremor seriously affected the patient’s daily activities and
quality of life. Several drugs were tried, including pramipexole extended
release 3 mg once a day, levodopa/carbidopa 250/25 mg four times a
day, valproic acid 500 mg twice a day, levetiracetam 1 g twice a day,
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quetiapine 50 mg twice a day, gabapentin 600 mg twice a day,
clonazepam 2 mg twice a day, and agomelatine 50 mg once a day,
all of them titrated to maximum doses, without tremor improve-
ment. Deep brain stimulation (DBS) and thalamotomy were
excluded because of the high risk of procedure-related complica-
tions. On September 2017, she was admitted to our center;
neurological examination showed a left spastic hemiparesis with
brisk deep tendon reflexes and a left severe resting, postural,
and intention tremor. The patient’s consent was obtained prior to
recording the video (Video 1). The basal Fahn–Tolosa–Marin
Tremor Rating Scale scored 76 points (range, parts A + B + C 5
0–156). She marked the intensity of tremor as 9 out of 10 using the
visual analog scale (VAS).
After other drugs were discontinued, TPM was started at a dose
of 25 mg and titrated to 100 mg (50 mg twice a day). A tremor
improvement was observed at the highest dose (Video 2), allowing
her to be partially independent in the daily living activities, with no
negative impact on the emotional or cognitive sphere. At these doses,
the Fahn–Tolosa–Marin Tremor Rating Scale scored 41 points (53%
improvement) and 5 out of 10 on VAS.
Discussion
HT, midbrain tremor, or rubral tremor was first described
in 1904 by Gordon Holmes. It is a symptomatic, low frequency
(,4.5 Hz) tremor that predominantly affects the proximal limbs.
Some authors hypothesized that the delayed tremor onset after
lesion could be explained by a rearrangement of central pathways in
the brain or an aberrant result of plasticity.16 The HT treatment is a
challenge with moderate or poor response.17–20 Benzodiazepines,
propranolol, anticholinergics, channel-blockers, anticonvulsants
(lamotrigine, levetiracetam, valproic acid, zonisamide, gabapentin,
carbamazepine), atypical neuroleptics (quetiapine, clozapine), baclo-
fen, dopamine agonists (bromocriptine, pramipexole, piribedil), and
L-dopa are among the drugs with a variable success.21 Although, the
number of cases reported in the literature is small, L-dopa was the
leading one with a substantial outcome.22–24 This observation is in
order with the proposed functional deficit of nigrostriatal dopami-
nergic pathway.25,26
However, satisfactory clinical improvement following treatment
with L-dopa is not achieved in some patients, as in our case, and other
oral medications, botulinum toxin injections,27,28 or several surgical
procedures are required.29,30
TPM, an antiepileptic drug that was originally designed as an oral
hypoglycemic and subsequently approved as an anticonvulsant, is also
effective in reducing essential tremor (ET).
TPM blocks sodium channels and potentiates gamma-aminobutyric
acid activity, decreasing the thalamic output and cortex hyperexcitability.31,32
To the best of our knowledge, the present case is the first report
of TPM-responsive HT. After an extensive search in the literature,
we found the use of TPM in one HT patient of a series reported by
Figure 1. Brain MRI. ADC (Apparent diffusion coefficient) and FLAIR (fluid-attenuated inversion recovery) sequences showing a right lesion located at the
mesencephalon with diencephalic extension.
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Raina et al.33 but in this case TPM was included in the group of drugs
with poor or no response. Despite these controversial findings and the
lack of evidence, extensive research is still warranted to determine the
effectiveness of TPM in HT.34,35
In summary, in this patient, with a contraindication for surgical
approach36,37 (DBS or thalamic lesion) and lack of responsiveness
to various drugs, including L-dopa, TPM may be a useful drug to
improve HT with moderate benefits (about 50 % of tremor scales).
Figure 2. Brain MRI, Post-gadolinium Images. T2 and T1 sequences enhanced after the administration of gadolinium.
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